Shanghai OPM Biosciences Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 223.11 million compared to CNY 151.18 million a year ago. Revenue was CNY 223.11 million compared to CNY 151.18 million a year ago.

Net income was CNY 83.09 million compared to CNY 46.17 million a year ago. Basic earnings per share from continuing operations was CNY 0.9286 compared to CNY 0.5357 a year ago. Diluted earnings per share from continuing operations was CNY 0.9286 compared to CNY 0.5357 a year ago.